title: Effect of cysteamine injection on vasopressin and oxytocin biosynthesis in rat hypothalamus.
abstract: Cysteamine (CSH), a sulfhydryl agent that promotes disulfide-exchange reactions, was studied for its effects on the immunoreactive (IR) levels and synthesis of oxytocin and vasopressin in the hypothalamus. CSH injection (300 mg/kg s.c.) caused a rapid (1 h) suppression of 35S-cysteine incorporation into hypothalamic arginine vasopressin (VP) and oxytocin (OT). The reduction in labeling persisted for about 8 h; label incorporation was normal within 10 h of CSH administration. The drug did not influence 35S-cysteine incorporation into acid-precipitable protein, nor did it influence 35S-cysteine specific activity in the hypothalamus. In addition, 35S-VP and 35S-OT molecules could not be recovered from hypothalami of CSH-treated rats by subjecting samples to denaturing, reducing and then reoxidizing conditions. Despite the reduction in peptide labeling, CSH treatment produced no alterations in the IR VP and OT contents of hypothalamus or posterior pituitary. These results indicate that CSH causes a true suppression of both VP and OT formation in hypothalamus, and suggest that the effect is either too transient to promote a reduction in endogenous stores of either peptide, or that the drug equally inhibits peptide production and removal (i.e., axonal transport, secretion).
authors.affiliation: Department of Psychiatry, University of Pittsburgh School of Medicine, PA.
authors.forename: R P
authors.initials: RP
authors.lastname: Kwok
authors.forename: J L
authors.initials: JL
authors.lastname: Cameron
authors.forename: J D
authors.initials: JD
authors.lastname: Fernstrom
mesh_terms: D000818:Animals; D002851:Chromatography, High Pressure Liquid; D003543:Cysteamine / Q000494:pharmacology*; D003545:Cysteine / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010121:Oxytocin / Q000096:biosynthesis* / Q000276:immunology; D010904:Pituitary Gland, Posterior / Q000187:drug effects / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D017207:Rats, Sprague-Dawley; D013462:Sulfur Radioisotopes; D014667:Vasopressins / Q000096:biosynthesis* / Q000276:immunology
chemical_list: D013462:Sulfur Radioisotopes; D014667:Vasopressins; D010121:Oxytocin; D003543:Cysteamine; D003545:Cysteine